Freestone Grove Partners’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
Other funds holding NHC
MSIIA
Freestone Grove Partners's NHC Position: Q2 2026 in Review
Freestone Grove Partners sold out of National Healthcare (NHC) in Q2 2026, closing a stake of 1,229 shares — an estimated $196K sold.
Freestone Grove Partners first reported a position in NHC in Q1 2026 and held it in 1 quarter. The position peaked at $196K in Q1 2026. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.
- Freestone Grove Partners reported no remaining National Healthcare position as of Q2 2026 after selling out during the quarter.
- Freestone Grove Partners sold 1,229 National Healthcare shares in Q2 2026, an estimated $196K.
- Freestone Grove Partners first reported a position in National Healthcare in Q1 2026 and held it in 1 quarter.
- Freestone Grove Partners's National Healthcare position peaked at $196K in Q1 2026.
- 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.